BIO vs MSFT: Which Stock is Better?
Side-by-side comparison of Bio-Rad Laboratories Inc and Microsoft Corp in 2026
BIO
Bio-Rad Laboratories Inc
$278.44
MSFT
Microsoft Corp
$397.23
Key Metrics Comparison
| Metric | BIO | MSFT | Winner |
|---|---|---|---|
| Market Cap | $7.52B | N/A | BIO |
| P/E Ratio | 10.00 | 36.30 | BIO |
| EPS (TTM) | $27.85 | $13.70 | BIO |
| Revenue Growth | 0.0% | 14.9% | MSFT |
| Gross Margin | 52.0% | 68.8% | MSFT |
Analyze BIO
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is BIO or MSFT a better investment?
Comparing BIO and MSFT: Bio-Rad Laboratories Inc has a market cap of $7.52B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between BIO and MSFT?
BIO (Bio-Rad Laboratories Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: BIO or MSFT?
Based on P/E ratios, BIO trades at a lower multiple (10.0x vs 36.3x).
Which is growing faster: BIO or MSFT?
MSFT has higher revenue growth at 14.9% vs 0.0% for BIO.
Which company is more profitable: BIO or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.8% compared to 52.0% for BIO.
Which is the larger company: BIO or MSFT?
Bio-Rad Laboratories Inc (BIO) is larger with a market cap of $7.52B compared to N/A for MSFT.
Should I buy BIO or MSFT in 2026?
Both BIO and MSFT have investment merit. BIO trades at $278.44 while MSFT trades at $397.23. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between BIO and MSFT stock?
Key differences: Market Cap ($7.52B vs N/A), P/E Ratio (10.0x vs 36.3x), Revenue Growth (0.0% vs 14.9%), Gross Margin (52.0% vs 68.8%).